NCT07175701 Ultra-processed Food-reducing Intervention and Continuous Glucose Monitoring
| NCT ID | NCT07175701 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Korea University |
| Condition | Postprandial Glucose |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-10-11 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-10-11 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this trial is to investigate whether reduction in ultra-processed food intake through dietary counseling and education can improve postprandial glucose responses and glycemic variability compared with a usual diet in young, healthy Korean adults aged 20-30 years. The main questions it aims to answer are: \- Does reducing ultra-processed food intake, while maintaining total energy intake and usual lifestyle behaviors, improve postprandial glucose and lower glycemic variability in healthy adults without diabetes? Participants will: * Undergo the 10-day pre-intervention monitoring period, during which each participant will wear a continuous glucose monitoring (CGM) device and concurrently report their daily dietary intakes (all food and beverage consumption) and other lifestyle behaviors (sleep, smoking, physical activity) * After the 10-day pre-intervention monitoring period, participants will be randomized to either intervention or control group * Intervention group: Participants will visit the research site to receive dietitian-led one-on-one nutrition education and personalized dietary counseling targeting reduction of ultra-processed food intake. Personalized diet counseling will be provided by study dietitian based on participant's records of dietary intakes during the 10-day pre-intervention monitoring period. * Control group: Participants will receive dietitian-led nutrition education and personalized dietary counseling based on the national dietary guidelines. * After the intervention, participants will undergo the 10-day post-intervention monitoring period, during which participants will wear a new CGM device for an additional 10 days and continue daily reporting of dietary intakes (all food and beverage consumptions) and lifestyle behaviors (sleep, smoking, physical activity).
Eligibility Criteria
Inclusion Criteria: 1. Korean adults aged 20-39 years 2. Not currently pregnant 3. No personal history of diabetes or other glucose-related conditions 4. Consume ≥25% of daily energy intake from UPFs, as assessed by an online, self-administered semi-quantitative screening food frequency questionnaire (FFQ) 5. No restriction on wearing a CGM device 6. No increased risk of bleeding 7. No prior adverse reaction to CGM devices 8. Willingness to participate in follow-up assessments Exclusion Criteria: 1. Unable to maintain continuous follow-up during the study period (e.g., due to special plans such as traveling) 2. Planning to follow a special or restrictive diet (e.g., for weight loss) during the study period
Contact & Investigator
Hannah Oh, ScD
PRINCIPAL INVESTIGATOR
Department of Health Policy and Management, Korea University, Seoul, Republic of Korea
Frequently Asked Questions
Who can join the NCT07175701 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 39 Years, studying Postprandial Glucose. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07175701 currently recruiting?
Yes, NCT07175701 is actively recruiting participants. Contact the research team at iamyujin@korea.ac.kr for enrollment information.
Where is the NCT07175701 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07175701 clinical trial?
NCT07175701 is sponsored by Korea University. The principal investigator is Hannah Oh, ScD at Department of Health Policy and Management, Korea University, Seoul, Republic of Korea. The trial plans to enroll 50 participants.